220 related articles for article (PubMed ID: 18024792)
1. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.
Hoemme C; Peerzada A; Behre G; Wang Y; McClelland M; Nieselt K; Zschunke M; Disselhoff C; Agrawal S; Isken F; Tidow N; Berdel WE; Serve H; Müller-Tidow C
Blood; 2008 Mar; 111(5):2887-95. PubMed ID: 18024792
[TBL] [Abstract][Full Text] [Related]
2. Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia.
Saeed S; Logie C; Francoijs KJ; Frigè G; Romanenghi M; Nielsen FG; Raats L; Shahhoseini M; Huynen M; Altucci L; Minucci S; Martens JH; Stunnenberg HG
Blood; 2012 Oct; 120(15):3058-68. PubMed ID: 22923494
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo.
Atsumi A; Tomita A; Kiyoi H; Naoe T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1471-80. PubMed ID: 16730330
[TBL] [Abstract][Full Text] [Related]
4. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
[TBL] [Abstract][Full Text] [Related]
5. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
Rice KL; Hormaeche I; Doulatov S; Flatow JM; Grimwade D; Mills KI; Leiva M; Ablain J; Ambardekar C; McConnell MJ; Dick JE; Licht JD
Blood; 2009 Dec; 114(27):5499-511. PubMed ID: 19855079
[TBL] [Abstract][Full Text] [Related]
7. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
[TBL] [Abstract][Full Text] [Related]
8. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
[TBL] [Abstract][Full Text] [Related]
10. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
11. [Transcriptional regulation of BHLHB2 induced by PML-RARα].
Jia XH; Yang WT; Zhu XH; Yang XW; Zhang J; Wang KK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1005-9. PubMed ID: 21867633
[TBL] [Abstract][Full Text] [Related]
12. PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.
Saulle E; Petronelli A; Pelosi E; Coppotelli E; Pasquini L; Ilari R; Lo-Coco F; Testa U
J Hematol Oncol; 2016 Apr; 9():33. PubMed ID: 27052408
[TBL] [Abstract][Full Text] [Related]
13. Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
[TBL] [Abstract][Full Text] [Related]
14. UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation.
Shah SJ; Blumen S; Pitha-Rowe I; Kitareewan S; Freemantle SJ; Feng Q; Dmitrovsky E
Mol Cancer Ther; 2008 Apr; 7(4):905-14. PubMed ID: 18413804
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of genome-wide PLZF/RARA target genes.
Spicuglia S; Vincent-Fabert C; Benoukraf T; Tibéri G; Saurin AJ; Zacarias-Cabeza J; Grimwade D; Mills K; Calmels B; Bertucci F; Sieweke M; Ferrier P; Duprez E
PLoS One; 2011; 6(9):e24176. PubMed ID: 21949697
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
17. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
[TBL] [Abstract][Full Text] [Related]
18. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
19. Activation of
Zhang F; Zhu YL; Deng WL; Zhu J; Zhang J
J Leukoc Biol; 2017 Mar; 101(3):655-664. PubMed ID: 27605212
[TBL] [Abstract][Full Text] [Related]
20. PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.
Martens JH; Brinkman AB; Simmer F; Francoijs KJ; Nebbioso A; Ferrara F; Altucci L; Stunnenberg HG
Cancer Cell; 2010 Feb; 17(2):173-85. PubMed ID: 20159609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
